For the first two years of the Covid-19 pandemic, health care professionals focused on understanding the Covid-19 virus, how best to guard against it, and developed tests to detect it. They also tracked, aggregated, and analyzed health data to assess and monitor the public health threat on a regional, state and national level.

In the longer term, vaccine development and distribution helped slow the spread to avoid  collapse of the health care system. More recently, attention has shifted to the long-perceived threat of viruses coming together with Covid-19, the flu, RSV and Group A Strep occurring alongside the Covid-19 virus.

Watch this on-demand presentation as we explore the state of play of the Covid-19 virus coming together with other viruses in the current landscape. Is this a perfect storm of contagions?

What role can diagnostics play to accurately ascertain and diagnose infected members of the population?

Among the talking points of the webinar will be:

• An overview of the most recent respiratory seasons and the risks
  posed by RSV, flu, and other respiratory diseases
• Clinical presentation and symptoms 
• Impact on children and the pediatric population
• The BD Veritor™ Plus System and its benefits
• Innovations that companies such as BD have enacted to support public health
  
  

                                                                Webinar Panel

Nikos Pavlidis, Vice President, General Manager, Diagnostics, BD
Vice President, General Manager of Diagnostics at BD Integrated Diagnostic Solutions and focuses on both the execution of the long-term strategy as well as the achievement of short-term business goals for the molecular diagnostics, microbiology and point-of-care platforms.

Nikos joined BD nearly 25 years ago and has held various customer support, sales and marketing roles within Europe, including leading the BD IDS commercial organizations across Northwest Europe. In 2013, Nikos joined the Global BD IDS organization and relocated to the division’s global headquarters in Sparks, Maryland. From 2018 to 2021, he led the BD IDS efforts around Inclusion and Diversity, driving initiatives that fostered programs around conscious inclusion, internal talent development and talent acquisition.

Having dedicated more than two decades working closely with healthcare professionals, Nikos understands the value and impact of diagnostics in clinical decision-making in high- and mid-throughput labs, as well as the shift to non-traditional care settings, including home and retail locations. He strongly believes that broader assay menus, combination testing and self-collection will improve access to diagnostics and help address health inequities in diagnosis and ultimately in treatment, reducing the burden of disease through earlier more accurate diagnosis and guided use of antibiotics. Nikos serves on the University of Maryland Foundation Board of Trustees and holds a bachelor’s degree in biomedical engineering from the University of Athens Greece as well as an MSc in biomedical engineering from the University of Dundee, UK. 

Cindy Prins, PhD, MPH, CIC, CPH
Clinical Associate Professor of Epidemiology, Epidemiology PhD Program Director, University of Florida
Cindy received her PhD in biochemistry, microbiology, and molecular biology from Penn State University in 2000, where she studied replication of JC virus. She completed her post-doctoral training at the University of Florida, focusing on regulation of vaccinia virus transcription elongation. Concurrently, she earned her MPH in Epidemiology from the University of Florida in 2006. After this she worked in Infection Prevention and Control at UF Health Shands Hospital before becoming a faculty member in Epidemiology at the University of Florida in 2010. Dr. Prins is active in the professional infection control and hospital epidemiology community and currently conducts research related to infection prevention and control in long-term care facilities.

Michelle Prickett, MD
Associate Professor of Medicine, Northwestern University Feinberg School of Medicine
Dr. Prickett is an Associate Professor of Pulmonary and Critical Care Medicine at Northwestern University Feinberg School of Medicine.  She serves as medical director of respiratory care for Northwestern Memorial Hospital and is a practicing outpatient pulmonologist as well as a bedside intensivist. Dr. Prickett was one on the first physicians to care for patients with confirmed COVID-19 in spring of 2020 and has remained active in efforts to reduce transmission of the virus in her hospital and community through promotion of screening and education.

Fill out the form and sign up today!